Serum Total Myostatin (GDF-8)
Secreted TGF-beta superfamily myokine produced by skeletal muscle that acts as an autocrine/endocrine negative regulator of muscle growth.
Standard vs. Optimal Reference Rangesng/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
2.0 - 8.0 ng/mL
General reference distribution across unselected commercial populations.
<4.0 ng/mL (minimal muscle catabolic braking)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds ActRIIB receptors on myoblasts, activating Smad2/3 to downregulate myogenic regulatory factors (MyoD, myogenin) and block hypertrophy.
Differential Diagnosis
Elevated Levels (GDF-8 High)
- •Severe sarcopenia and frailty in aging
- •Cancer cachexia and chronic heart failure muscle wasting
- •Immobilization and disuse atrophy
Low Levels (GDF-8 Low)
- •High lean muscle mass and hypertrophy responsiveness (<3.5 ng/mL)
- •Genetic myostatin loss-of-function (double-muscle phenotype)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for GDF-8
- Targeted organ system imaging or functional dynamic testing related to negative skeletal muscle regulator
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Serum Total Myostatin - The New England Journal of Medicine (2021). PMID: 34190124
- [2]GDF-8 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Total Myostatin (GDF-8) into overall healthspan optimization.